[144] Zimmer Biomet Holdings, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Zimmer Biomet Holdings, Inc. (ZBH) shows a proposed sale of 1,200 common shares through Fidelity Brokerage Services on 09/11/2025 with an aggregate market value of $124,302.00. The filing reports 198,095,984 shares outstanding for the issuer and lists the planned exchange as the NYSE. The securities being offered were acquired by restricted stock vesting on 03/01/2024 (1,144 shares) and 03/06/2024 (56 shares), with payment characterized as compensation.

The filing also discloses prior sales by the same person, Sang Uk Yi, of 1,000 shares on 06/11/2025 for $95,000.00 and 800 shares on 06/13/2025 for $74,010.96. The signer certifies no undisclosed material adverse information and acknowledges the Rule 144 representation and criminal penalties for misstatements.

Insights

Securities Analyst

TL;DR Small planned sale relative to outstanding shares; routine insider filing showing disposition of vested restricted stock.

The Form 144 documents a proposed sale of 1,200 shares by an insider through Fidelity on 09/11/2025, following recent disposals of 1,800 shares in June 2025. Acquisitions were from restricted stock vesting in March 2024 and paid as compensation. Given the issuer's reported 198,095,984 shares outstanding, the sizes disclosed are immaterial to capitalization and unlikely to affect market pricing. The filing meets Rule 144 disclosure mechanics and includes the standard insider certification regarding material non-public information.

Corporate Governance Specialist

TL;DR Compliance-oriented disclosure; no governance red flags appear from the information provided.

This notice is a routine compliance filing for an insider sale of vested restricted stock. The filer affirms no undisclosed material adverse information and references Rule 10b5-1 plan mechanics where applicable. There are no indications of unusual concentrations, related-party transactions, or accelerated insider activity in the data supplied. Documentation of acquisition dates and prior June sales supports transparency around timing and sourcing of the shares sold.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1200	124302.00	198095984	09/11/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/01/2024	Restricted Stock Vesting	Issuer			1144	03/01/2024	Compensation
Common	03/06/2024	Restricted Stock Vesting	Issuer			56	03/06/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Sang Uk Yi 345 East Main Street Warsaw IN 46580	Common	06/11/2025	1000	95000.00
Sang Uk Yi 345 East Main Street Warsaw IN 46580	Common	06/13/2025	800	74010.96

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for ZBH report?

The Form 144 reports a proposed sale of 1,200 common shares via Fidelity on 09/11/2025 with aggregate market value $124,302.00.

Who is the reported seller in this filing?

The filing identifies the seller as Sang Uk Yi with prior reported sales in June 2025.

How were the shares being sold acquired?

The shares were acquired through restricted stock vesting on 03/01/2024 (1,144 shares) and 03/06/2024 (56 shares) and were paid as compensation.

What prior sales does the Form 144 disclose?

The filer sold 1,000 shares on 06/11/2025 for $95,000.00 and 800 shares on 06/13/2025 for $74,010.96.

Which exchange is the planned sale to occur on?

The planned sale is listed for the NYSE.